摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-1-[3-β-D-(glucopyranosyloxy)-5-hydroxyphenyl]-2-(4-β-D-glucopyranosyloxyphenyl)ethene

中文名称
——
中文别名
——
英文名称
(E)-1-[3-β-D-(glucopyranosyloxy)-5-hydroxyphenyl]-2-(4-β-D-glucopyranosyloxyphenyl)ethene
英文别名
resveratrol 3,4′-O-di-β-D-glucopyranoside;trans-resveratrol-3,4'-di-O-β-D-glucopyranoside;resveratrol 3,4'-(O,O'-di-β-D-glucopyranoside);resveratrol 3,4'-O,O'-di-β-D-glucopyranoside;resveratrol 3,4'-di-O-β-D-glucopyranoside;resveratrol-3,4'-di-β-D-glucopyranoside;(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-[(E)-2-[3-hydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethenyl]phenoxy]oxane-3,4,5-triol
(E)-1-[3-β-D-(glucopyranosyloxy)-5-hydroxyphenyl]-2-(4-β-D-glucopyranosyloxyphenyl)ethene化学式
CAS
——
化学式
C26H32O13
mdl
——
分子量
552.532
InChiKey
YGQPMDDXSJHKJT-VUNDNAJOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    39
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    219
  • 氢给体数:
    9
  • 氢受体数:
    13

反应信息

  • 作为产物:
    描述:
    (E)-1-[3-{[tert-butyl(dimethyl)silyl]oxy}-5-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyloxy)phenyl]-2-[4-(2,3,4,6-tetra-O-benzoyl-β-D-glucopyranosyloxy)phenyl]ethene 在 sodium hydroxide 作用下, 以 四氢呋喃甲醇 为溶剂, 反应 5.0h, 以99%的产率得到(E)-1-[3-β-D-(glucopyranosyloxy)-5-hydroxyphenyl]-2-(4-β-D-glucopyranosyloxyphenyl)ethene
    参考文献:
    名称:
    Synthesis of Mono- and Di-O-β-d-glucopyranoside Conjugates of (E)-Resveratrol
    摘要:
    从市售天然产物(E)-白藜芦醇(1)出发,通过一步反应制备了四种选择性叔丁基二甲基硅基(TBS)保护的(E)-白藜芦醇衍生物 6-9。以 6-9 作为糖基受体,三氟乙酰亚胺 11 作为糖基供体,高效地通过两步反应合成了三种具有生物活性的天然葡萄糖苷(E)-白藜芦醇偶联物 2-4 和一个新化合物(5)。
    DOI:
    10.1055/s-2006-926394
点击查看最新优质反应信息

文献信息

  • Synthesis of Mono- and Di-<i>O</i>-β-<scp>d</scp>-glucopyranoside Conjugates of (<i>E</i>)-Resveratrol
    作者:Zhaojun Zhang、Biao Yu、Richard Schmidt
    DOI:10.1055/s-2006-926394
    日期:2006.4
    Starting from the commercially available natural product (E)-resveratrol (1), the four selectively tert-butyldimethylsilyl (TBS) protected (E)-resveratrols 6-9 were prepared by one reaction. Using 6-9 as glucosyl acceptors and trifluoroacetimidate 11 as glucosyl donor, three bioactive natural glucopyranoside conjugates of (E)-resveratrol 2-4 and one novel compound (5) were efficiently prepared in two steps.
    从市售天然产物(E)-白藜芦醇(1)出发,通过一步反应制备了四种选择性叔丁基二甲基硅基(TBS)保护的(E)-白藜芦醇衍生物 6-9。以 6-9 作为糖基受体,三氟乙酰亚胺 11 作为糖基供体,高效地通过两步反应合成了三种具有生物活性的天然葡萄糖苷(E)-白藜芦醇偶联物 2-4 和一个新化合物(5)。
  • Assessing the Regioselectivity of OleD-Catalyzed Glycosylation with a Diverse Set of Acceptors
    作者:Maoquan Zhou、Adel Hamza、Chang-Guo Zhan、Jon S. Thorson
    DOI:10.1021/np300890h
    日期:2013.2.22
    To explore the acceptor regioselectivity of OleD-catalyzed glucosylation, the products of OleD-catalyzed reactions with six structurally diverse acceptors flavones— (daidzein), isoflavones (flavopiridol), stilbenes (resveratrol), indole alkaloids (10-hydroxycamptothecin), and steroids (2-methoxyestradiol)—were determined. This study highlights the first synthesis of flavopiridol and 2-methoxyestradiol
    为了探索 OleD 催化葡萄糖基化的受体区域选择性,OleD 催化反应的产物与六种结构不同的受体黄酮(黄豆苷原)、异黄酮(flavopiridol)、芪(白藜芦醇)、吲哚生物碱(10-羟基喜树碱(10-羟基喜树碱)、 2-甲氧基雌二醇)-测定。该研究重点介绍了黄酮醇和 2-甲氧基雌二醇糖苷的首次合成,并证实了 OleD 对芳香族和脂肪族亲核试剂进行葡萄糖基化的能力。在所有情况下,分子动力学模拟与确定的产品分布一致,并表明开发虚拟筛选模型以识别其他 OleD 底物的潜力。
  • Regioselective Glucosylation of Aromatic Compounds: Screening of a Recombinant Glycosyltransferase Library to Identify Biocatalysts
    作者:Markus Weis、Eng-Kiat Lim、Neil Bruce、Dianna Bowles
    DOI:10.1002/anie.200504505
    日期:2006.5.19
  • Substrate specificities of family 1 UGTs gained by domain swapping
    作者:Esben Halkjær Hansen、Sarah A. Osmani、Charlotte Kristensen、Birger Lindberg Møller、Jørgen Hansen
    DOI:10.1016/j.phytochem.2009.01.013
    日期:2009.3
    Family 1 glycosyltransferases are a group of enzymes known to embrace a large range of different substrates. This study devises a method to enhance the range of substrates even further by combining domains from different glycosyltransferases to gain improved substrate specificity and catalytic efficiency. Chimeric glycosyltransferases were made by combining domains from seven different family 1 glycosyltransferases, UGT71C1, UGT71C2, UGT71E1, UGT85C1, UGT85B1, UGT88B1 and UGT94B1. Twenty different chimeric glycosyltransferases were formed of which twelve were shown to be catalytically active. The chimeric enzymes of Arabidopsis thaliana UGT71C1 and UGT71C2 showed major changes in acceptor substrate specificity and were able to glycosylate etoposide significantly better than the parental UGT71C1 and UGT71C2 enzymes, with K-cat and efficiency coefficients 3.0 and 2.6 times higher, respectively. Chimeric glycosyltransferases of UGT71C1 combined with Stevia rebaudiana UGT71E1, also afforded enzymes with high catalytic efficiency, even though the two enzymes only display 38% amino acid sequence identity. These chimeras show a significantly altered regiospecificity towards especially trans-resveratrol, enabling the production of trans-resveratrol-beta-4'-O-glucoside (resveratroloside). The study demonstrates that it is possible to obtain improved catalytic properties by combining domains from both closely as well as more distantly related glycosyltransferases. The substrate specificity gained by the chimeras is difficult to predict because factors determining the acceptor specificity reside in the N-terminal as well as the C-terminal domains. (C) 2009 Elsevier Ltd. All rights reserved.
  • [EN] COMPOSITION COMPRISING A MORUS ALBA EXTRACT, AND ITS COSMETIC USES<br/>[FR] COMPOSITION COMPRENANT UN EXTRAIT DE MORUS ALBA ET SES UTILISATIONS COSMÉTIQUES
    申请人:OREAL
    公开号:WO2020201432A1
    公开(公告)日:2020-10-08
    The present invention relates to a composition comprising, in a physiologically acceptable medium, at least mulberroside A and mulberroside E. It also relates to cosmetic uses of said composition, especially for depigmenting, lightening and/or bleaching keratin materials, in particular the skin.
查看更多

同类化合物

(E,Z)-他莫昔芬N-β-D-葡糖醛酸 (E/Z)-他莫昔芬-d5 (4S,5R)-4,5-二苯基-1,2,3-恶噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R,4''R,5S,5''S)-2,2''-(1-甲基亚乙基)双[4,5-二氢-4,5-二苯基恶唑] (1R,2R)-2-(二苯基膦基)-1,2-二苯基乙胺 鼓槌石斛素 高黄绿酸 顺式白藜芦醇三甲醚 顺式白藜芦醇 顺式己烯雌酚 顺式-桑皮苷A 顺式-曲札芪苷 顺式-二苯乙烯 顺式-beta-羟基他莫昔芬 顺式-a-羟基他莫昔芬 顺式-3,4',5-三甲氧基-3'-羟基二苯乙烯 顺式-1,2-二苯基环丁烷 顺-均二苯乙烯硼酸二乙醇胺酯 顺-4-硝基二苯乙烯 顺-1-异丙基-2,3-二苯基氮丙啶 阿非昔芬 阿里可拉唑 阿那曲唑二聚体 阿托伐他汀环氧四氢呋喃 阿托伐他汀环氧乙烷杂质 阿托伐他汀环(氟苯基)钠盐杂质 阿托伐他汀环(氟苯基)烯丙基酯 阿托伐他汀杂质D 阿托伐他汀杂质94 阿托伐他汀内酰胺钠盐杂质 阿托伐他汀中间体M4 阿奈库碘铵 银松素 铒(III) 离子载体 I 钾钠2,2'-[(E)-1,2-乙烯二基]二[5-({4-苯胺基-6-[(2-羟基乙基)氨基]-1,3,5-三嗪-2-基}氨基)苯磺酸酯](1:1:1) 钠{4-[氧代(苯基)乙酰基]苯基}甲烷磺酸酯 钠;[2-甲氧基-5-[2-(3,4,5-三甲氧基苯基)乙基]苯基]硫酸盐 钠4-氨基二苯乙烯-2-磺酸酯 钠3-(4-甲氧基苯基)-2-苯基丙烯酸酯 重氮基乙酸胆酯酯 醋酸(R)-(+)-2-羟基-1,2,2-三苯乙酯 酸性绿16 邻氯苯基苄基酮 那碎因盐酸盐 那碎因[鹼] 达格列净杂质54 辛那马维林 赤藓型-1,2-联苯-2-(丙胺)乙醇 赤松素 败脂酸,丁基丙-2-烯酸酯,甲基2-甲基丙-2-烯酸酯,2-甲基丙-2-烯酸